These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28218867)
61. [Treatment of hepatitis B and C -- current standards]. Zeuzem S Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169 [No Abstract] [Full Text] [Related]
62. [Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Indications for Treatment]. Kim KA Korean J Gastroenterol; 2016 Mar; 67(3):123-6. PubMed ID: 26996180 [TBL] [Abstract][Full Text] [Related]
63. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839 [TBL] [Abstract][Full Text] [Related]
64. Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders. Chayama K; Takahashi S; Toyota J; Karino Y; Ikeda K; Ishikawa H; Watanabe H; McPhee F; Hughes E; Kumada H Hepatology; 2012 Mar; 55(3):742-8. PubMed ID: 21987462 [TBL] [Abstract][Full Text] [Related]
65. Hepatitis B virus: from diagnosis to treatment. Dény P; Zoulim F Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167 [TBL] [Abstract][Full Text] [Related]
66. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)]. Rao HY; Duan ZP; Wang GQ; Wei L Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062 [TBL] [Abstract][Full Text] [Related]
67. An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver. Myers RP; Ramji A; Bilodeau M; Wong S; Feld JJ Can J Gastroenterol; 2012 Jun; 26(6):359-75. PubMed ID: 22720279 [TBL] [Abstract][Full Text] [Related]
68. Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges. Soriano V; Tefferi A Cancer; 2018 Apr; 124(8):1647-1649. PubMed ID: 29486060 [No Abstract] [Full Text] [Related]
69. Treatment Options in Hepatitis C. Zeuzem S Dtsch Arztebl Int; 2017 Jan; 114(1-02):11-21. PubMed ID: 28143635 [TBL] [Abstract][Full Text] [Related]
70. Hepatitis C in Pregnancy in the Era of Direct-acting Antiviral Treatment: Potential Benefits of Universal Screening and Antepartum Therapy. Bernstein HB; Dunkelberg JC; Leslie KK Clin Obstet Gynecol; 2018 Mar; 61(1):146-156. PubMed ID: 29351151 [TBL] [Abstract][Full Text] [Related]
71. [How to treat non-responders to antiviral bitherapy for hepatitis C?]. Guyader D Gastroenterol Clin Biol; 2007 Mar; 31(3):317-24. PubMed ID: 17396096 [No Abstract] [Full Text] [Related]
73. The Second Canadian Symposium on hepatitis C virus: a call to action. Grebely J; Bilodeau M; Feld JJ; Bruneau J; Fischer B; Raven JF; Roberts E; Choucha N; Myers RP; Sagan SM; Wilson JA; Bialystok F; Tyrrell DL; Houghton M; Krajden M; Can J Gastroenterol; 2013 Nov; 27(11):627-32. PubMed ID: 24199209 [TBL] [Abstract][Full Text] [Related]
74. Screening for Hepatitis C Virus: How Universal Is Universal? Jhaveri R Clin Ther; 2020 Aug; 42(8):1434-1441. PubMed ID: 32712026 [TBL] [Abstract][Full Text] [Related]
75. [Guideline for the prevention and treatment of hepatitis C (2022 version)]. ; Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1332-1348. PubMed ID: 36891719 [TBL] [Abstract][Full Text] [Related]
76. Management of chronic hepatitis C: consensus guidelines. Sherman M; Shafran S; Burak K; Doucette K; Wong W; Girgrah N; Yoshida E; Renner E; Wong P; Deschênes M Can J Gastroenterol; 2007 Jun; 21 Suppl C(Suppl C):25C-34C. PubMed ID: 17568824 [TBL] [Abstract][Full Text] [Related]
77. Reflex testing. A key tool for the elimination of hepatitis C. Herrero JI; Ampuero J; Fernández Rodríguez CM Rev Esp Enferm Dig; 2020 Jul; 112(7):513-514. PubMed ID: 32611193 [TBL] [Abstract][Full Text] [Related]
80. New therapeutic options for HCV in Central Europe. Flisiak R; Urbánek P; Rokusz L; Oltman M; Makara M; Janicko M Clin Exp Hepatol; 2016 Mar; 2(1):7-11. PubMed ID: 28856265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]